Cite
HARVARD Citation
Melotti, A. et al. (n.d.). The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT‐TCF pathway responses in human cancer. EMBO molecular medicine. 6 (10), pp. 1263-1278. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Melotti, A. et al. (n.d.). The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT‐TCF pathway responses in human cancer. EMBO molecular medicine. 6 (10), pp. 1263-1278. [Online].